Cite
HARVARD Citation
Rose, R. et al. (2022). Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc. AIDS. pp. 11-18. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rose, R. et al. (2022). Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc. AIDS. pp. 11-18. [Online].